This Mason-based startup just raised $4M. Here’s how it will use the funds

A Mason-based early-stage biopharma startup that's developing a new pipeline of drugs to treat disorders like osteoarthritis closed a $4 million seed round this month, marking a significant stepping stone for the company, officials said.